Biobank for patients with inflammatory chronic diseases and osteoporosis
Official title: Biobank for Inflammatory Chronic Diseases and Osteoporosis of TOULouse
Run by University Hospital, Toulouse · NCT05039216 · Data updated 2026-11-12
This study is creating a biobank to collect samples from patients with chronic inflammatory diseases and osteoporosis to see if they can find markers that help doctors choose better treatments.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 99 Years |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | University Hospital, Toulouse Academic / other |
| Locations | 1 site (Toulouse) |
| Status | Recruiting |
| Started | September 13, 2021 |
| Main results expected | September 2, 2026 |
| Study ends | September 1, 2031 |
| Registry record updated | March 19, 2026 |
| Trial ID | NCT05039216 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with rheumatoid arthritis, psoriatic arthritis, spondyloarthritis, or osteoporosis who are starting a new treatment.
✕Probably not a fit
Patients who are pregnant, breastfeeding, unable to consent, or have severe anemia will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to create a biobank for patients at the Rheumatology center of Toulouse University Hospital who have chronic inflammatory rheumatism, such as rheumatoid arthritis, spondyloarthritis, or psoriatic arthritis, as well as those with osteoporosis. By collecting and storing biological samples from these patients, the study seeks to identify biomarkers that are associated with therapeutic responses to various treatments. This will help physicians make more informed decisions regarding treatment options based on predictive clinical and biological factors. The biobank will also focus on understanding the severity of osteoporosis and the effectiveness of anti-osteoporotic treatments.
Why it matters
Potential benefit: If successful, this study could lead to more personalized and effective treatment strategies for patients with chronic inflammatory diseases and osteoporosis.
How similar studies have gone: Other studies have shown success in identifying biomarkers for treatment responses in similar chronic inflammatory conditions, making this approach promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Chronic inflammatory rheumatism including RA, SpA or PsA or patients with primary or secondary osteoporosis * With National Health Assurance * Able to consent to the study Exclusion Criteria: * Pregnancy or breastfeeding * Not able to give a consent * Severe anemia (Hb\<10g/L)
Where it's running
-
Purpan University Hospital
Toulouse, France Recruiting
Study contacts
- Principal investigator: Adeline RUYSSEN-WITRAND, MD — University Hospital, Toulouse
- Study coordinator: Adeline RUYSSEN-WITRAND, MD
- Email: ruyssen-witrand.a@chu-toulouse.fr
- Phone: 561775626
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Creating Health online course for people with rheumatological conditions
This project will test whether an online course about diet and self-care helps adults with rheumatoid arthritis, Sjogren's syndrome, lupus, mixed connective tissue disease, or psoriatic arthritis reduce fatigue and improve quality of life.
-
Follow-up care for new cases of polyarthritis in children and young adults
This program will try standardized medical follow-up for children and young adults (≤50) with new-onset JIA, RA, psoriatic/seronegative/undifferentiated arthritis, SLE, or diffuse systemic sclerosis who are treatment-naïve or treated ≤3 months to see if more patients reach disease control or remission.
-
Impact of ultra-processed foods on rheumatic diseases
This study looks at how eating ultra-processed foods might affect people with chronic rheumatic diseases like rheumatoid arthritis and osteoarthritis to see if it makes their symptoms worse.
-
Study on how diet affects autoimmune diseases in rheumatology patients
This study looks at how changing to a healthier diet, like the Mediterranean diet, might help people with autoimmune diseases feel better and manage their symptoms.
-
Using capsule fecal microbiota transplantation to treat newly diagnosed chronic inflammatory diseases
This study is testing if taking capsules containing healthy gut bacteria can help people recently diagnosed with chronic inflammatory diseases feel better.
-
Educational tool for melanoma patients with autoimmune diseases
This study is testing a new educational tool to help melanoma patients with autoimmune diseases understand their treatment options better and see how easy it is for them to use.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.